{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T02:55:02Z","timestamp":1772938502479,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,7]]},"DOI":"10.7759\/cureus.104805","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T09:00:47Z","timestamp":1772874047000},"source":"Crossref","is-referenced-by-count":0,"title":["A Narrative Review of Childhood Myopia Management Across the NHS and Private Sector in the UK"],"prefix":"10.7759","author":[{"given":"Hammaad","family":"Khalid","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mishelle","family":"Abbasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Mohyudin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"American Optometric Association. Myopia (nearsightedness). (2025). Accessed: December 7, 2025: https:\/\/www.aoa.org\/healthy-eyes\/eye-and-vision-conditions\/myopia."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0146332","article-title":"Six year refractive change among white children and young adults: evidence for significant increase in myopia among white UK children","volume":"11","author":"McCullough SJ","year":"2016","unstructured":"McCullough SJ, O'Donoghue L, Saunders KJ. Six year refractive change among white children and young adults: evidence for significant increase in myopia among white UK children. PLoS One. 2016, 11:e0146332. 10.1371\/journal.pone.0146332","journal-title":"PLoS One"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2016.01.006","article-title":"Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050","volume":"123","author":"Holden BA","year":"2016","unstructured":"Holden BA, Fricke TR, Wilson DA, et al.. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology. 2016, 123:1036-42. 10.1016\/j.ophtha.2016.01.006","journal-title":"Ophthalmology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.66.4.82","article-title":"Absolute risks and decision tools for communicating the risks of visual impairment from myopia-related diseases","volume":"66","author":"Dow E","year":"2025","unstructured":"Dow E, Kearney S, Day M. Absolute risks and decision tools for communicating the risks of visual impairment from myopia-related diseases. Invest Ophthalmol Vis Sci. 2025, 66:82. 10.1167\/iovs.66.4.82","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.62.10.36","article-title":"Myopia progression as a function of sex, age, and ethnicity","volume":"62","author":"Jones-Jordan LA","year":"2021","unstructured":"Jones-Jordan LA, Sinnott LT, Chu RH, et al.. Myopia progression as a function of sex, age, and ethnicity. Invest Ophthalmol Vis Sci. 2021, 62:36. 10.1167\/iovs.62.10.36","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref6","unstructured":"NHS. Short-sightedness (myopia). (2025). Accessed: December 8, 2025: https:\/\/www.nhs.uk\/conditions\/short-sightedness\/."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfma.2022.05.005","article-title":"Efficacy of atropine, orthokeratology, and combined atropine with orthokeratology for childhood myopia: a systematic review and network meta-analysis","volume":"121","author":"Tsai HR","year":"2022","unstructured":"Tsai HR, Wang JH, Huang HK, Chen TL, Chen PW, Chiu CJ. Efficacy of atropine, orthokeratology, and combined atropine with orthokeratology for childhood myopia: a systematic review and network meta-analysis. J Formos Med Assoc. 2022, 121:2490-500. 10.1016\/j.jfma.2022.05.005","journal-title":"J Formos Med Assoc"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0291470","article-title":"Global risk factor analysis of myopia onset in children: a systematic review and meta-analysis","volume":"18","author":"Yu M","year":"2023","unstructured":"Yu M, Hu Y, Han M, et al.. Global risk factor analysis of myopia onset in children: a systematic review and meta-analysis. PLoS One. 2023, 18:e0291470. 10.1371\/journal.pone.0291470","journal-title":"PLoS One"},{"key":"ref9","unstructured":"Principles of managing children with myopia. (2025). Accessed. February 2026: https:\/\/www.college-optometrists.org\/clinical-guidance\/guidance\/knowledge."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2020.0412","article-title":"Association of parental myopia with higher risk of myopia among multiethnic children before school age","volume":"138","author":"Jiang X","year":"2020","unstructured":"Jiang X, Tarczy-Hornoch K, Cotter SA, et al.. Association of parental myopia with higher risk of myopia among multiethnic children before school age. JAMA Ophthalmol. 2020, 138:501-9. 10.1001\/jamaophthalmol.2020.0412","journal-title":"JAMA Ophthalmol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-72240-y","article-title":"Axial growth and refractive change in white European children and young adults: predictive factors for myopia","volume":"10","author":"McCullough S","year":"2020","unstructured":"McCullough S, Adamson G, Breslin KM, McClelland JF, Doyle L, Saunders KJ. Axial growth and refractive change in white European children and young adults: predictive factors for myopia. Sci Rep. 2020, 10:15189. 10.1038\/s41598-020-72240-y","journal-title":"Sci Rep"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1177\/00099228261422296","article-title":"Clinical implications of diet inflammatory index in celiac patients","author":"G\u00fclseren A","year":"2026","unstructured":"G\u00fclseren A, Besparmak A, Kaya N. Clinical implications of diet inflammatory index in celiac patients. Clin Pediatr (Phila). 2026, 99228261422296. 10.1177\/00099228261422296","journal-title":"Clin Pediatr (Phila)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s40101-024-00354-7","article-title":"The influence of the environment and lifestyle on myopia","volume":"43","author":"Biswas S","year":"2024","unstructured":"Biswas S, El Kareh A, Qureshi M, et al.. The influence of the environment and lifestyle on myopia. J Physiol Anthropol. 2024, 43:7. 10.1186\/s40101-024-00354-7","journal-title":"J Physiol Anthropol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.24595","article-title":"Smartwatch measures of outdoor exposure and myopia in children","volume":"7","author":"Chen J","year":"2024","unstructured":"Chen J, Wang J, Qi Z, et al.. Smartwatch measures of outdoor exposure and myopia in children. JAMA Netw Open. 2024, 7:e2424595. 10.1001\/jamanetworkopen.2024.24595","journal-title":"JAMA Netw Open"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-024-06719-z","article-title":"Measuring the visual environment of children and young people at risk of myopia: a scoping review","volume":"263","author":"Dahlmann-Noor AH","year":"2025","unstructured":"Dahlmann-Noor AH, Bokre D, Khazova M, Price LL. Measuring the visual environment of children and young people at risk of myopia: a scoping review. Graefes Arch Clin Exp Ophthalmol. 2025, 263:1213-28. 10.1007\/s00417-024-06719-z","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref16","unstructured":"College of Optometrists. Myopia management guidance: FAQs. (2025). Accessed: December 12, 2025: https:\/\/www.college-optometrists.org\/category-landing-pages\/clinical-topics\/myopia\/myopia-management-guidance-faqs."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/OPX.0000000000001410","article-title":"A 3-year randomized clinical trial of MiSight lenses for myopia control","volume":"96","author":"Chamberlain P","year":"2019","unstructured":"Chamberlain P, Peixoto-de-Matos SC, Logan NS, Ngo C, Jones D, Young G. A 3-year randomized clinical trial of MiSight lenses for myopia control. Optom Vis Sci. 2019, 96:556-67. 10.1097\/OPX.0000000000001410","journal-title":"Optom Vis Sci"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/OPX.0000000000001873","article-title":"Long-term effect of dual-focus contact lenses on myopia progression in children: a 6-year multicenter clinical trial","volume":"99","author":"Chamberlain P","year":"2022","unstructured":"Chamberlain P, Bradley A, Arumugam B, et al.. Long-term effect of dual-focus contact lenses on myopia progression in children: a 6-year multicenter clinical trial. Optom Vis Sci. 2022, 99:204-12. 10.1097\/OPX.0000000000001873","journal-title":"Optom Vis Sci"},{"key":"ref19","unstructured":"College of Optometrists. \u200bOrthokeratology in clinical practice. (2025). Accessed: December 13, 2025: https:\/\/www.college-optometrists.org\/professional-development\/college-journals\/optometry-in-practice\/volume-17,-issue...."},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.11-8005","article-title":"Myopia control with orthokeratology contact lenses in Spain: refractive and biometric changes","volume":"53","author":"Santodomingo-Rubido J","year":"2012","unstructured":"Santodomingo-Rubido J, Villa-Collar C, Gilmartin B, Guti\u00e9rrez-Ortega R. Myopia control with orthokeratology contact lenses in Spain: refractive and biometric changes. Invest Ophthalmol Vis Sci. 2012, 53:5060-5. 10.1167\/iovs.11-8005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.12-10565","article-title":"Retardation of myopia in Orthokeratology (ROMIO) study: a 2-year randomized clinical trial","volume":"53","author":"Cho P","year":"2012","unstructured":"Cho P, Cheung SW. Retardation of myopia in Orthokeratology (ROMIO) study: a 2-year randomized clinical trial. Invest Ophthalmol Vis Sci. 2012, 53:7077-85. 10.1167\/iovs.12-10565","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1097\/OPX.0000000000000505","article-title":"Orthokeratology for myopia control: a meta-analysis","volume":"92","author":"Si JK","year":"2015","unstructured":"Si JK, Tang K, Bi HS, Guo DD, Guo JG, Wang XR. Orthokeratology for myopia control: a meta-analysis. Optom Vis Sci. 2015, 92:252-7. 10.1097\/OPX.0000000000000505","journal-title":"Optom Vis Sci"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2018-313739","article-title":"Defocus incorporated multiple segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomised clinical trial","volume":"104","author":"Lam CS","year":"2020","unstructured":"Lam CS, Tang WC, Tse DY, et al.. Defocus incorporated multiple segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomised clinical trial. Br J Ophthalmol. 2020, 104:363-8. 10.1136\/bjophthalmol-2018-313739","journal-title":"Br J Ophthalmol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2022.0401","article-title":"Spectacle lenses with aspherical lenslets for myopia control vs single-vision spectacle lenses: a randomized clinical trial","volume":"140","author":"Bao J","year":"2022","unstructured":"Bao J, Huang Y, Li X, et al.. Spectacle lenses with aspherical lenslets for myopia control vs single-vision spectacle lenses: a randomized clinical trial. JAMA Ophthalmol. 2022, 140:472-8. 10.1001\/jamaophthalmol.2022.0401","journal-title":"JAMA Ophthalmol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1097\/ICL.0000000000000677","article-title":"Biological mechanisms of atropine control of myopia","volume":"46","author":"Upadhyay A","year":"2020","unstructured":"Upadhyay A, Beuerman RW. Biological mechanisms of atropine control of myopia. Eye Contact Lens. 2020, 46:129-35. 10.1097\/ICL.0000000000000677","journal-title":"Eye Contact Lens"},{"key":"ref26","unstructured":"College of Optometrists. MHRA approves first licensed low-dose atropine treatment for childhood myopia in the UK. (2025). Accessed: December 14, 2025: https:\/\/www.college-optometrists.org\/news\/2025\/november\/mhra-licensed-low-dose-atropine-myopia."},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.14744\/bej.2022.07742","article-title":"Role of atropine in the control of myopia progression- a review","volume":"7","author":"Kaiti R","year":"2022","unstructured":"Kaiti R, Shyangbo R, Sharma IP. Role of atropine in the control of myopia progression- a review. Beyoglu Eye J. 2022, 7:157-66. 10.14744\/bej.2022.07742","journal-title":"Beyoglu Eye J"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2006.05.062","article-title":"Atropine for the treatment of childhood myopia","volume":"113","author":"Chua WH","year":"2006","unstructured":"Chua WH, Balakrishnan V, Chan YH, Tong L, Ling Y, Quah BL, Tan D. Atropine for the treatment of childhood myopia. Ophthalmology. 2006, 113:2285-91. 10.1016\/j.ophtha.2006.05.062","journal-title":"Ophthalmology"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2018.05.029","article-title":"Low-Concentration Atropine for Myopia Progression (LAMP) study: a randomized, double-blinded, placebo-controlled trial of 0.05%, 0.025%, and 0.01% atropine eye drops in myopia control","volume":"126","author":"Yam JC","year":"2019","unstructured":"Yam JC, Jiang Y, Tang SM, et al.. Low-Concentration Atropine for Myopia Progression (LAMP) study: a randomized, double-blinded, placebo-controlled trial of 0.05%, 0.025%, and 0.01% atropine eye drops in myopia control. Ophthalmology. 2019, 126:113-24. 10.1016\/j.ophtha.2018.05.029","journal-title":"Ophthalmology"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.24162","article-title":"Effect of low-concentration atropine eyedrops vs placebo on myopia incidence in children: the LAMP2 randomized clinical trial","volume":"329","author":"Yam JC","year":"2023","unstructured":"Yam JC, Zhang XJ, Zhang Y, et al.. Effect of low-concentration atropine eyedrops vs placebo on myopia incidence in children: the LAMP2 randomized clinical trial. JAMA. 2023, 329:472-81. 10.1001\/jama.2022.24162","journal-title":"JAMA"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1136\/bjo-2023-323887","article-title":"Advances in myopia control strategies for children","volume":"109","author":"Zhang XJ","year":"2025","unstructured":"Zhang XJ, Zaabaar E, French AN, et al.. Advances in myopia control strategies for children. Br J Ophthalmol. 2025, 109:165-76. 10.1136\/bjo-2023-323887","journal-title":"Br J Ophthalmol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.61.4.49","article-title":"The complications of myopia: a review and meta-analysis","volume":"61","author":"Haarman AE","year":"2020","unstructured":"Haarman AE, Enthoven CA, Tideman JW, Tedja MS, Verhoeven VJ, Klaver CC. The complications of myopia: a review and meta-analysis. Invest Ophthalmol Vis Sci. 2020, 61:49. 10.1167\/iovs.61.4.49","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/467225-a-narrative-review-of-childhood-myopia-management-across-the-nhs-and-private-sector-in-the-uk","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T09:00:48Z","timestamp":1772874048000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/467225-a-narrative-review-of-childhood-myopia-management-across-the-nhs-and-private-sector-in-the-uk"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,7]]},"references-count":32,"URL":"https:\/\/doi.org\/10.7759\/cureus.104805","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,7]]}}}